FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

75030011000036103: human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram + human papillomavirus (type 6) vaccine 20 microgram injection, 0.5 mL syringe (medicinal product unit of use)


    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    431840011000036114 human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram + human papillomavirus (type 6) vaccine 20 microgram injection, 0.5 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    431841011000036119 human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe Is a medicinal product unit of use false Inferred relationship Some
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe Is a human papillomavirus (type 6) vaccine + human papillomavirus (type 11) vaccine + human papillomavirus (type 16) vaccine + human papillomavirus (type 18) vaccine false Inferred relationship Some
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has intended active ingredient human papillomavirus (type 6) vaccine false Inferred relationship Some 504760942
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has Australian BoSS human papillomavirus (type 6) vaccine false Inferred relationship Some 504760942
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has intended active ingredient human papillomavirus (type 11) vaccine false Inferred relationship Some 1297582998
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has Australian BoSS human papillomavirus (type 11) vaccine false Inferred relationship Some 1297582998
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has intended active ingredient human papillomavirus (type 16) vaccine false Inferred relationship Some 601209076
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has Australian BoSS human papillomavirus (type 16) vaccine false Inferred relationship Some 601209076
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has intended active ingredient human papillomavirus (type 18) vaccine false Inferred relationship Some 2088936216
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has Australian BoSS human papillomavirus (type 18) vaccine false Inferred relationship Some 2088936216
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has manufactured dose form injection false Inferred relationship Some
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has unit of use syringe false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Gardasil injection suspension, 0.5 mL syringe Is a False human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe Inferred relationship Some
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe has MPUU False human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe Inferred relationship Some
    human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 10 x 0.5 mL syringes has MPUU False human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start